37921 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 26
00:38 UTC
|
FIS
Fidelity National Information Services
|
◎ Target | David Koning ★★★★☆ #578 | Neutral | $48.00→ $45.00-6.2% |
|
Sep 26
00:38 UTC
|
EMR
Emerson Electric
|
◎ Target | Joe Giordano not yet tracked | Hold | $150.00→ $170.00+13.3% |
|
Sep 26
00:38 UTC
|
DRI
Darden Restaurants
|
◎ Target | Jon Tower ★★★☆☆ #2209 | Buy | $248.00→ $247.00-0.4% |
|
Sep 26
00:38 UTC
|
DRI
Darden Restaurants
|
◎ Target | Andrew Strelzik ★★☆☆☆ #2857 | Market Perform | $225.00→ $220.00-2.2% |
|
Sep 26
00:38 UTC
|
DRI
Darden Restaurants
|
◎ Target | Nick Setyan ★★★☆☆ #1826 | Outperform | $235.00→ $245.00+4.3% |
|
Sep 26
00:38 UTC
|
DMRA
Damora Therapeutics, Inc. Common Stock
|
◎ Target | Brad Canino not yet tracked | Buy | $40.00→ $60.00+50.0% |
|
Sep 26
00:38 UTC
|
CVX
Chevron
|
◎ Target | Kim Fustier ★★★★★ #36 | Buy | $218.00→ $250.00+14.7% |
|
Sep 26
00:38 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Justin Bowers ★★★★★ #59 | Buy | $300.00→ $320.00+6.7% |
|
Sep 26
00:38 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Charles Rhyee ★★★★★ #278 | Buy | $300.00→ $325.00+8.3% |
|
Sep 26
00:38 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Luke Sergott ★★★★★ #56 | Overweight | $300.00→ $330.00+10.0% |
|
Sep 26
00:38 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Eric Coldwell ★★★★☆ #434 | Outperform | $291.00→ $334.00+14.8% |
|
Sep 26
00:38 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Ann Hynes ★★★★★ #33 | Neutral | $264.00→ $295.00+11.7% |
|
Sep 26
00:38 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Ryan Halsted ★★★★★ #311 | Outperform | $282.00→ $322.00+14.2% |
|
Sep 26
00:38 UTC
|
CPT
Camden Property Trust
|
◎ Target | Michael Lewis ★★★☆☆ #1407 | Buy | $123.00→ $108.00-12.2% |
|
Sep 26
00:38 UTC
|
COST
Costco Wholesale
|
◎ Target | David Belinger not yet tracked | Outperform | $1,100.00→ $1,065.00-3.2% |
|
Sep 26
00:38 UTC
|
COST
Costco Wholesale
|
◎ Target | Edward Kelly ★★★☆☆ #1024 | Equal Weight | $1,000.00→ $950.00-5.0% |
|
Sep 26
00:38 UTC
|
COST
Costco Wholesale
|
◎ Target | Zhihan Ma ★★★★☆ #417 | Outperform | $1,144.00→ $1,143.00-0.1% |
|
Sep 26
00:38 UTC
|
COST
Costco Wholesale
|
◎ Target | Georgy Vashchenko not yet tracked | Buy | $1,030.00→ $1,010.00-1.9% |
|
Sep 26
00:38 UTC
|
COST
Costco Wholesale
|
◎ Target | Christopher Horvers ★★★★☆ #508 | Overweight | $1,100.00→ $1,015.00-7.7% |
|
Sep 26
00:38 UTC
|
COST
Costco Wholesale
|
◎ Target | Michael Baker ★★★★☆ #656 | Neutral | $1,000.00→ $1,040.00+4.0% |
|
Sep 26
00:38 UTC
|
COST
Costco Wholesale
|
◎ Target | Scot Ciccarelli ★★★★☆ #953 | Hold | $1,011.00→ $955.00-5.5% |
|
Sep 26
00:38 UTC
|
COST
Costco Wholesale
|
◎ Target | Bobby Griffin ★★★★☆ #906 | Outperform | $1,100.00→ $1,050.00-4.5% |
|
Sep 26
00:38 UTC
|
CGEM
Cullinan Therapeutics
|
◎ Target | Robert Burns ★☆☆☆☆ #2977 | Buy | $30.00→ $35.00+16.7% |
|
Sep 26
00:38 UTC
|
CBRL
Cracker Barrel Old Country Store
|
◎ Target | Jon Tower ★★★☆☆ #2209 | Sell | $42.00→ $44.00+4.8% |
|
Sep 26
00:38 UTC
|
BNY
Bank of New York Mellon
|
◎ Target | David Smith not yet tracked | Buy | $178.00→ $172.00-3.4% |
|
Sep 26
00:38 UTC
|
BLK
BlackRock
|
◎ Target | Michael Cyprys ★★★★☆ #934 | Overweight | $1,488.00→ $1,479.00-0.6% |
|
Sep 26
00:38 UTC
|
BGO
Bango
|
◎ Target | firm only | Buy | GBX 181→ GBX 160-11.6% |
|
Sep 26
00:38 UTC
|
BEN
Franklin Resources
|
◎ Target | Michael Cyprys ★★★★☆ #934 | Equal Weight | $34.00→ $35.00+2.9% |
|
Sep 26
00:38 UTC
|
BB
BlackBerry
|
◎ Target | Michael Walkley not yet tracked | Hold | $10.30→ $9.50-7.8% |
|
Sep 26
00:38 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Sean Laaman ★★★☆☆ #1277 | Equal Weight | $251.00→ $247.00-1.6% |
|
Sep 26
00:38 UTC
|
AXGN
AxoGen
|
◎ Target | Jayson Bedford ★★★★☆ #657 | Outperform | $48.00→ $53.00+10.4% |
|
Sep 26
00:38 UTC
|
AO
AO World
|
◎ Target | firm only | Buy | GBX 160→ GBX 155-3.1% |
|
Sep 26
00:38 UTC
|
ANDG
Andersen Group
|
◎ Target | Tobey Sommer ★★★★★ #184 | Buy | $55.00→ $70.00+27.3% |
|
Sep 26
00:38 UTC
|
AMD
Advanced Micro Devices
|
◎ Target | Vivek Arya ★★☆☆☆ #2698 | Buy | $620.00→ $720.00+16.1% |
|
Sep 26
00:38 UTC
|
ALLY
Ally Financial
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $58.00→ $50.00-13.8% |
|
Sep 26
00:38 UTC
|
AKAM
Akamai Technologies
|
◎ Target | Madeline Brooks ★★★★☆ #571 | Buy | $175.00→ $185.00+5.7% |
|
Sep 26
00:38 UTC
|
AKAM
Akamai Technologies
|
◎ Target | John DiFucci ★★★★★ #42 | Buy | $190.00→ $225.00+18.4% |
|
Sep 26
00:38 UTC
|
AKAM
Akamai Technologies
|
◎ Target | Roger Boyd ★★★★★ #17 | Neutral | $143.00→ $148.00+3.5% |
|
Sep 26
00:38 UTC
|
AKAM
Akamai Technologies
|
◎ Target | Michael Elias ★★☆☆☆ #2451 | Hold | $140.00→ $149.00+6.4% |
|
Sep 26
00:38 UTC
|
AKAM
Akamai Technologies
|
◎ Target | Samik Chatterjee ★★★☆☆ #980 | Neutral | $158.00→ $167.00+5.7% |
|
Sep 26
00:38 UTC
|
AJG
Arthur J. Gallagher & Co.
|
◎ Target | Bob Huang ★★★★☆ #482 | Overweight | $290.00→ $285.00-1.7% |
|
Sep 26
00:38 UTC
|
AEE
Ameren
|
◎ Target | Stephen D'Ambrisi ★★★☆☆ #1493 | Sec→ r Perform | $114.00→ $107.00-6.1% |
|
Sep 26
00:38 UTC
|
ACN
Accenture
|
◎ Target | Tien-Tsin Huang not yet tracked | Overweight | $179.00→ $200.00+11.7% |
|
Sep 26
00:38 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Ananda Ghosh ★★★☆☆ #1667 | Buy | $37.00→ $33.00-10.8% |
|
Sep 26
00:38 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $36.00→ $33.00-8.3% |
|
Sep 26
00:38 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | David Hoang ★★☆☆☆ #2524 | Buy | $38.00→ $31.00-18.4% |
|
Sep 26
00:38 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Ami Fadia ★★☆☆☆ #2379 | Buy | $41.00→ $35.00-14.6% |
|
Sep 26
00:38 UTC
|
AAMI
Acadian Asset Management
|
◎ Target | Michael Cyprys ★★★★☆ #934 | Equal Weight | $81.00→ $95.00+17.3% |
|
Sep 25
19:37 UTC
|
COST
Costco Wholesale
|
◎ Target | Georgy Vashchenko not yet tracked | Buy | $1,030.00→ $1,010.00-1.9% |
|
Sep 25
17:37 UTC
|
TFIN
Triumph Financial
|
◎ Target | Michael Rose ★★★★☆ #572 | Outperform | $89.00→ $84.00-5.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.